Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bio-PRF vs Alveogyl for Alveolar Osteitis
NCT05615272Unknown
- Sponsor
- Trinity College Dublin
- Start
- Oct 2022
- Primary completion
- Mar 2024
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
Randomised trial of Bio-PRF in alveolar osteitis (AO) (2 arms), sponsored by Trinity College Dublin. Primary endpoint: Change in postoperative pain levels at 7 days. Status: unknown.
02
Drugs
Bio-PRF
03
Conditions
alveolar osteitis (AO)
Beyond the preview
Go deeper on NCT05615272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05615272.